SCHEMBL1870221

SCHEMBL1870221

CC1(C)C2[CH]CC1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3651851 0.62
SCHEMBL3655408 0.62
SCHEMBL16241603 0.62
SCHEMBL6290928 0.61
SCHEMBL2320997 0.60 ALDH1A1 (0.31)
Hydrogen Sulfide SCHEMBL15657582 0.59
SCHEMBL15003323 0.57
SCHEMBL18393525 0.56
SCHEMBL1496227 0.56
SCHEMBL5896876 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858641-B2 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-12-28 US claimed
US-7456183-B2 Guanidino compounds NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-11-25 US claimed
US-7189727-B2 Guanidino compounds CHIRON CORPORATION (US) 2007-03-13 US claimed
EP-1385823-B1 GUANIDINO COMPOUNDS AS MELANOCORTIN-4 RECEPTOR (MC4-R) AGONISTS CHIRON CORP (US) 2006-12-13 EP claimed
US-6960582-B2 Guanidino compounds CHIRON CORPORATION (US) 2005-11-01 US claimed
US-20050124652-A1 Guanidino compounds BOYCE RUSTUM (US) 2005-06-09 US claimed
US-20040248895-A1 Novel guanidino compounds CHU DANIEL (US) 2004-12-09 US claimed
EP-1478626-A2 GUANIDINO COMPOUNDS CHIRON CORPORATION (US) 2004-11-24 EP claimed
US-6713650-B2 ELEVATES ATP BINDING CASSETTE TRANSPORTER 1 EXPRESSION THEREBY INCREASING EFFLUX OF CHOLESTEROL FROM CELLS BY ACTIVE TRANSFER INTO HIGH DENSITY LIPOPROTEINS CV THERAPEUTICS, INC. 2004-03-30 US claimed
WO-2003103651-A1 COMPOUNDS OF THE FORMU;A R1-X-Y-Z-NR2R3 AS ABCA-1 ELEVATING AGENTS AGAINST CAD OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2003-12-18 WO claimed
US-20030195187-A1 Guanidino compounds CHIRON CORPORATION 2003-10-16 US claimed
WO-2003066597-A2 GUANIDINO COMPOUNDS CHIRON CORPORATION (US) 2003-08-14 WO claimed
US-20020082257-A1 ABCA-1 Elevating compounds CV THERAPEUTICS, INC. 2002-06-27 US claimed
EP-0284084-B1 INTENSELY SWEET L-ASPARTYL-3-(BICYCLOALKYL)-L-ALANINE ALKYL ESTERS THE COCA-COLA COMPANY (US) 1991-06-26 EP claimed
US-4788069-A SWEETENING EDIBLE FOODS AND BEVERAGES THE COCA-COLA COMPANY (US) 1988-11-29 US claimed
WO-1988007522-A1 INTENSELY SWEET L-ASPARTYL-3-(BICYCLOALKYL)-L-ALANINE ALKYL ESTERS THE COCA-COLA COMPANY (US) 1988-10-06 WO claimed
EP-0284084-A2 Intensely sweet L-aspartyl-3-(Bicycloalkyl)-L-alanine alkyl esters THE COCA-COLA COMPANY (US) 1988-09-28 EP claimed
US-4404274-A Photographic light sensitive element containing yellow color coupler and method for forming yellow photographic images FUJI PHOTO FILM CO., LTD. (JP) 1983-09-13 US claimed
EP-4097274-A1 METHOD FOR REDUCING OR PREVENTING CORROSION OR FOULING CAUSED BY ACIDIC COMPOUNDS Kurita Water Industries Ltd. (JP) 2022-12-07 EP disclosed
US-3960570-A ALPHA-ACYLACETOAMIDE YELLOW DYE FORMING COUPLER FUJI PHOTO FILM CO., LTD. (JA) 1976-06-01 US disclosed